We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Response to Gene-targeted Drugs Depends on Cancer Type

News   Jul 02, 2019 | Original story from ICR

 
Response to Gene-targeted Drugs Depends on Cancer Type
 
 
 

RELATED ARTICLES

Heart Attack Modeled With Human Stem Cells

News

Researchers have modeled myocardial infarction using human stem cells, which may provide a useful platform for drug development without the need for sacrificing animals.

READ MORE

A Genetic Exploration of Ancient Rome

News

A new study reveals the genetic secrets of Ancient Rome, including how major events in the city’s history are reflected in its genetic history.

READ MORE

A New Treatment Approach for Type 2 Diabetes?

News

The protein adipsin helps protect insulin-secreting cells called pancreatic beta cells from destruction in Type 2 diabetes, according to a new research.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE